Gene · 835
Papers3,745
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,745
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of in vitro antiviral activity of SARS-CoV-2 Mpro inhibitor pomotrelvir and cross-resistance to nirmatrelvir resistance substitutions. | Antimicrob Agents Chemother | 2023 | 37800975 | PubTator, text mining | PubMed |
| Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration. | Front Pharmacol | 2023 | 37790807 | PubTator, text mining | PubMed |
| CEGA: a method for inferring natural selection by comparative population genomic analysis across species. | Genome Biol | 2023 | 37789379 | PubTator, text mining | PubMed |
| Role of hypoxic exosomes and the mechanisms of exosome release in the CNS under hypoxic conditions. | Front Neurol | 2023 | 37786863 | PubTator, text mining | PubMed |
| Modulation of wheatgrass (Triticum aestivum Linn) toxicity against breast cancer cell lines by simulated microgravity. | Curr Res Toxicol | 2023 | 37767028 | PubTator, text mining | PubMed |
| Recent Studies in Photodynamic Therapy for Cancer Treatment: From Basic Research to Clinical Trials. | Pharmaceutics | 2023 | 37765226 | PubTator, text mining | PubMed |
| Isorhamnetin Influences the Viability, Superoxide Production and Interleukin-8 Biosynthesis of Human Colorectal Adenocarcinoma HT-29 Cells In Vitro. | Life (Basel) | 2023 | 37763324 | PubTator, text mining | PubMed |
| Transcriptomic profiling of mare endometrium at different stages of endometrosis. | Sci Rep | 2023 | 37758834 | PubTator, text mining | PubMed |
| Overview and prospect of NAFLD: Significant roles of nutrients and dietary patterns in its progression or prevention. | Hepatol Commun | 2023 | 37756016 | PubTator, text mining | PubMed |
| Autophagy, a critical element in the aging male reproductive disorders and prostate cancer: a therapeutic point of view. | Reprod Biol Endocrinol | 2023 | 37749573 | PubTator, text mining | PubMed |
| ER stress: an emerging regulator in GVHD development. | Front Immunol | 2023 | 37744326 | PubTator, text mining | PubMed |
| Synergistic effects of flavonoids and paclitaxel in cancer treatment: a systematic review. | Cancer Cell Int | 2023 | 37743502 | PubTator, text mining | PubMed |
| Spatiotemporal, optogenetic control of gene expression in organoids. | Nat Methods | 2023 | 37735569 | PubTator, text mining | PubMed |
| Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium. | Mol Neurodegener | 2023 | 37735444 | PubTator, text mining | PubMed |
| Total recall: the role of PIDDosome components in neurodegeneration. | Trends Mol Med | 2023 | 37716905 | PubTator, text mining | PubMed |
| Endoplasmic reticulum stress: molecular mechanism and therapeutic targets. | Signal Transduct Target Ther | 2023 | 37709773 | PubTator, text mining | PubMed |
| Tumor suppressor p53 mediates interleukin-6 expression to enable cancer cell evasion of genotoxic stress. | Cell Death Discov | 2023 | 37696858 | PubTator, text mining | PubMed |
| Endoplasmic Reticulum Stress in Systemic Lupus Erythematosus and Lupus Nephritis: Potential Therapeutic Target. | J Immunol Res | 2023 | 37692838 | PubTator, text mining | PubMed |
| Marine Natural Compound (Neviotin A) Displays Anticancer Efficacy by Triggering Transcriptomic Alterations and Cell Death in MCF-7 Cells. | Molecules | 2023 | 37687120 | PubTator, text mining | PubMed |
| Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer-A Step before Anakoinosis-Based Personalized Treatment. | Cancers (Basel) | 2023 | 37686523 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/835/papers?page=8